PHILADELPHIA – Arthur L. Caplan, Ph.D.,  the Emmanuel and Robert Hart Director of the Center for Bioethics and the Sydney D Caplan Professor of Bioethics at the University of Pennsylvania has been selected to receive the Patricia Price Browne Prize in Biomedical Ethics, administered by the University of Oklahoma College of Medicine. The $10,000 prize, given every two years, was established to honor the Oklahoma City community leader Patricia Price Browne, by selecting an individual who “demonstrates the highest standards in the medical or professional ethics fields.”

Dr. Caplan is among the nation’s pre-eminent scholars and commentators in the field of biomedical ethics, having authored or edited twenty-nine books and over 500 papers in refereed journals. His most recent book is the Penn Guide to Bioethics (Springer, 2009).

“Dr. Caplan has provided a consistently high level of research and analysis relating to the ethical quandaries posed by today’s relentless advances of medical science and technology,” said Terrence Stull, MD. Chairman, Department of Pediatrics, University of Oklahoma Health Sciences Center on behalf of the selection committee. “On the biomedical hot-button topics that generate sensational headlines, Dr. Caplan provides a reasoned, measured, and wise perspective that the public can rely upon.”

Dr. Caplan has served on a number of national and international committees including as the Chair, National Cancer Institute Biobanking Ethics Working Group; the Chair of the Advisory Committee to the United Nations on Human Cloning; the Chair of the Advisory Committee to the Department of Health and Human Services on Blood Safety and Availability; a member of the Presidential Advisory Committee on Gulf War Illnesses; the special advisory committee to the International Olympic Committee on genetics and gene therapy;  and most recently was the Co-Director of the Joint Council of Europe/United Nations Study on Trafficking in Organs and Body Parts.

Caplan writes a regular column on bioethics for He is a frequent guest and commentator on various media outlets.


Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $5.3 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 18 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $373 million awarded in the 2015 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center -- which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report -- Chester County Hospital; Lancaster General Health; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2015, Penn Medicine provided $253.3 million to benefit our community.

Share This Page: